RMD has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
RMD has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-03-28), ResMed's share price is $198.03. ResMed's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $7.32. Hence, ResMed's Price-to-Operating-Cash-Flow Ratio for today is 27.07.
The historical rank and industry rank for ResMed's Price-to-Operating-Cash-Flow or its related term are showing as below:
During the past 13 years, ResMed's highest Price-to-Operating-Cash-Flow Ratio was 101.30. The lowest was 15.58. And the median was 29.23.
ResMed's Cash Flow from Operations per share for the three months ended in Dec. 2023 was $1.85. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $7.32.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of ResMed was 190.70% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -5.10% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 1.50% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 4.50% per year.
During the past 13 years, ResMed's highest 3-Year average Operating Cash Flow per Share Growth Rate was 78.60% per year. The lowest was -9.10% per year. And the median was 21.70% per year.
The historical data trend for ResMed's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, ResMed's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, ResMed's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where ResMed's Price-to-Operating-Cash-Flow falls into.
ResMed's Price-to-Operating-Cash-Flow ratio for today is calculated as
Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
= | 198.03 | / | 7.315 | |
= | 27.07 |
ResMed's Share Price of today is $198.03.
ResMed's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.32.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Price-to-Operating-Cash-Flow Ratio | = | Market Cap | / | Cash Flow from Operations |
Thank you for viewing the detailed overview of ResMed's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Brett Sandercock | officer: Chief Financial Officer | 17 GUINEVIERE COURT, CASTLE HILL, NEW SOUTH WALES C3 2154 |
Michael J. Farrell | officer: Chief Executive Officer | C/O REMED INC, 9001 SPECTRUM CTR. BLVD., SAN DIEGO, CA 92123 |
Michael J Rider | officer: Global General Counsel | 9001 SPECTRUM CENTER BLVD, SAN DIEGO CA 92123 |
Robert Andrew Douglas | officer: President and COO | 21 ATTUNGA ROAD, NEWPORT, NEW SOUTH WALES C3 2106 |
Kaushik Ghoshal | officer: President, SaaS Business | 9001 SPECTRUM CENTER BLVD, SAN DIEGO CA 92123 |
David Pendarvis | officer: Chief Administration Officer | REDMED INC, 14040 DANLELSON ST, POWAY CA 92064 |
Karen Drexler | director | C/O DIADEXUS, INC., 343 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO CA 94080 |
Justin Leong | officer: President, Asia and LATAM | C/O RESMED INC, 9001 SPECTRUM CENTER BLVD, SAN DIEGO CA 92123 |
Desney Tan | director | 9001 SPECTRUM CENTER BLVD, SAN DIEGO CA 92123 |
John Hernandez | director | 9001 SPECTRUM CENTER BLVD., SAN DIEGO CA 92123 |
Lucile Blaise | officer: President, Sleep & RC Business | RESMED INC., 9001 SPECTRUM CENTER BLVD., SAN DIEGO CA 92123 |
Peter C Farrell | director | RESMED INC, 14040 DANIELSON STREET, POWAY CA 92064-6857 |
James Hollingshead | officer: President, Sleep Business | C/O RESMED INC., 9001 SPECTRUM CENTER BOULEVARD, SAN DIEGO CA 92123 |
Carol Burt | director | C/O WELLCARE HEALTH PLANS, INC., 8725 HENDERSON ROAD, TAMPA FL 33634 |
Resmed Inc | director | 9001 SPECTRUM CENTER BLVD., SAN DIEGO CA 92123 |
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.